Application 071941
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DROPERIDOL | DROPERIDOL | Injectable; Injection | 2.5MG/ML | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Droperidol | DROPERIDOL | American Regent, Inc. | 147e033d-d997-4ef6-8bb5-a9ba372590b2 | 2023-03-20 | Boxed warning, Warnings, Adverse reactions | Droperidol DROPERIDOL |
| DROPERIDOL | DROPERIDOL | Hikma Pharmaceuticals USA Inc. | d89f33ac-8a6e-49e7-94fb-84e58aad65a8 | 2022-06-08 | Boxed warning, Warnings, Adverse reactions | DROPERIDOL DROPERIDOL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.